Senate panel questions Novo Nordisk CEO over decision to discontinue this popular insulin
During a Senate panel hearing Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen ... Novo Nordisk's decision to halt Levemir ...
NBC 10 Philadelphia1mon
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen ... Europe is a fraction of what it is in the United States," Sanders said in an interview Monday.
Renal & Urology News7h
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard ... the demand or projected demand for semaglutide within the United States exceeds the ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...